BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23714165)

  • 1. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.
    Fernandez-Feo M; Wei G; Blumenkranz G; Dewhirst FE; Schuppan D; Oppenheim FG; Helmerhorst EJ
    Clin Microbiol Infect; 2013 Sep; 19(9):E386-94. PubMed ID: 23714165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.
    Zamakhchari M; Wei G; Dewhirst F; Lee J; Schuppan D; Oppenheim FG; Helmerhorst EJ
    PLoS One; 2011; 6(9):e24455. PubMed ID: 21957450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
    Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
    Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
    Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
    PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.
    Wei G; Tian N; Siezen R; Schuppan D; Helmerhorst EJ
    Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G571-80. PubMed ID: 27469368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.
    Duar RM; Clark KJ; Patil PB; Hernández C; Brüning S; Burkey TE; Madayiputhiya N; Taylor SL; Walter J
    J Appl Microbiol; 2015 Feb; 118(2):515-27. PubMed ID: 25376327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.
    Tian N; Wei G; Schuppan D; Helmerhorst EJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G769-76. PubMed ID: 25147233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.
    Caminero A; Herrán AR; Nistal E; Pérez-Andrés J; Vaquero L; Vivas S; Ruiz de Morales JM; Albillos SM; Casqueiro J
    FEMS Microbiol Ecol; 2014 May; 88(2):309-19. PubMed ID: 24499426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
    Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ
    Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commensal Bacterium
    Wei G; Darwish G; Oppenheim FG; Schuppan D; Helmerhorst EJ
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.
    Berger M; Sarantopoulos C; Ongchangco D; Sry J; Cesario T
    Exp Biol Med (Maywood); 2015 Jul; 240(7):917-24. PubMed ID: 25519429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
    Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
    PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral proteases: a new approach to managing coeliac disease.
    Cerf-Bensussan N; Matysiak-Budnik T; Cellier C; Heyman M
    Gut; 2007 Feb; 56(2):157-60. PubMed ID: 16950833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coeliac disease--a meeting point for genetics, immunology, and protein chemistry.
    Mowat AM
    Lancet; 2003 Apr; 361(9365):1290-2. PubMed ID: 12699968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Structural Parallels between Gluten Pathogenic Peptides and Bacterial-Derived Proteins by Bioinformatics Analysis.
    Vazquez DS; Schilbert HM; Dodero VI
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Digestive Tract Is Capable of Degrading Gluten from Birth.
    Fernández-Pérez S; Pérez-Andrés J; Gutiérrez S; Navasa N; Martínez-Blanco H; Ferrero MÁ; Vivas S; Vaquero L; Iglesias C; Casqueiro J; Rodríguez-Aparicio LB
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human digestive tract has proteases capable of gluten hydrolysis.
    Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB
    Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements.
    Janssen G; Christis C; Kooy-Winkelaar Y; Edens L; Smith D; van Veelen P; Koning F
    PLoS One; 2015; 10(6):e0128065. PubMed ID: 26030273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Strategy to Discover Microbes with Gluten-degrading Enzyme Activities.
    Helmerhorst EJ; Wei G
    Proc SPIE Int Soc Opt Eng; 2014 May; 9112():. PubMed ID: 26113763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ; Ellis HJ
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.